1. Key Insights 2. Executive Summary of Liquid Biopsy in Cancer Diagnostics 3. Liquid Biopsy in Cancer Diagnostics: Background and Overview 3.1. Introduction 3.2. Types of Liquid Biopsy in Cancer Diagnostics 3.3. Advantages of Liquid Biopsy in Cancer Diagnostics 3.4. Disadvantages of Liquid Biopsy in Cancer Diagnostics 4. Liquid Biopsy in Cancer Diagnostics: Regulatory Scenario 5. Liquid Biopsy in Cancer Diagnostics: Reimbursement Scenario 6. Company Profiles 6.1. Lucence 6.1.1. Company Overview 6.1.2. Product Portfolio 6.1.2.1. Product description 6.1.2.2. Regulatory Milestones 6.1.2.3. Research and Development 6.1.2.4. Product Development Activities 6.2. Guardant Health 6.2.1. Company Overview 6.2.2. Product Portfolio 6.2.2.1. Product description 6.2.2.2. Regulatory Milestones 6.2.2.3. Research and Development 6.2.2.4. Product Development Activities More Companies in the final report… 7. Liquid Biopsy in Cancer Diagnostics: Competitive Analysis 8. KOL Views 9. Liquid Biopsy in Cancer Diagnostics: Market Analysis in 7MM 9.1. Liquid Biopsy in Cancer Diagnostics: Market Analysis in 7MM by Sample Type (2018–2026) 9.2. Liquid Biopsy in Cancer Diagnostics: Market Analysis in 7MM by Technique (2018–2026) 9.3. Liquid Biopsy in Cancer Diagnostics: Market Analysis in 7MM by Biomarker Type (2018–2026) 9.4. Liquid Biopsy in Cancer Diagnostics: Market Analysis in 7MM by End User (2018–2026) 10. Country-Wise Market size of Liquid Biopsy in Cancer Diagnostics in 7MM (2018–2026) 10.1. Market size of Liquid Biopsy in Cancer Diagnostics in the United States 10.1.1. Liquid Biopsy in Cancer Diagnostics: Market Analysis in the United States by Sample Type (2018–2026) 10.1.2. Liquid Biopsy in Cancer Diagnostics: Market Analysis in the United States by Technique (2018–2026) 10.1.3. Liquid Biopsy in Cancer Diagnostics: Market Analysis in the United States by Biomarker Type (2018–2026) 10.1.4. Liquid Biopsy in Cancer Diagnostics: Market Analysis in the United States by End User (2018–2026) 10.2. Market size of Liquid Biopsy in Cancer Diagnostics in Germany 10.2.1. Liquid Biopsy in Cancer Diagnostics: Market Analysis in Germany by Sample Type (2018–2026) 10.2.2. Liquid Biopsy in Cancer Diagnostics: Market Analysis in Germany by Technique (2018–2026) 10.2.3. Liquid Biopsy in Cancer Diagnostics: Market Analysis in the United States by Biomarker Type (2018–2026) 10.2.4. Liquid Biopsy in Cancer Diagnostics: Market Analysis in Germany by End User (2018–2026) 10.3. Market size of Liquid Biopsy in Cancer Diagnostics in France 10.3.1. Liquid Biopsy in Cancer Diagnostics: Market Analysis in France by Sample Type (2018–2026) 10.3.2. Liquid Biopsy in Cancer Diagnostics: Market Analysis in France by Technique (2018–2026) 10.3.3. Liquid Biopsy in Cancer Diagnostics: Market Analysis in France by Biomarker Type (2018–2026) 10.3.4. Liquid Biopsy in Cancer Diagnostics: Market Analysis in France by End User (2018–2026) 10.4. Market size of Liquid Biopsy in Cancer Diagnostics in Spain 10.4.1. Liquid Biopsy in Cancer Diagnostics: Market Analysis in Spain by Sample Type (2018–2026) 10.4.2. Liquid Biopsy in Cancer Diagnostics: Market Analysis in Spain by Technique (2018–2026) 10.4.3. Liquid Biopsy in Cancer Diagnostics: Market Analysis in Spain by Biomarker Type (2018–2026) 10.4.4. Liquid Biopsy in Cancer Diagnostics: Market Analysis in Spain by End User (2018–2026) 10.5. Market size of Liquid Biopsy in Cancer Diagnostics in Italy 10.5.1. Liquid Biopsy in Cancer Diagnostics: Market Analysis in Italy by Sample Type (2018–2026) 10.5.2. Liquid Biopsy in Cancer Diagnostics: Market Analysis in Italy by Technique (2018–2026) 10.5.3. Liquid Biopsy in Cancer Diagnostics: Market Analysis in Italy by Biomarker Type (2018–2026) 10.5.4. Liquid Biopsy in Cancer Diagnostics: Market Analysis in Italy by End User (2018–2026) 10.6. Market size of Liquid Biopsy in Cancer Diagnostics in UK 10.6.1. Liquid Biopsy in Cancer Diagnostics: Market Analysis in UK by Sample Type (2018–2026) 10.6.2. Liquid Biopsy in Cancer Diagnostics: Market Analysis in UK by Technique (2018–2026) 10.6.3. Liquid Biopsy in Cancer Diagnostics: Market Analysis in UK by Biomarker Type (2018–2026) 10.6.4. Liquid Biopsy in Cancer Diagnostics: Market Analysis in UK by End User (2018–2026) 10.7. Market size of Liquid Biopsy in Cancer Diagnostics in Japan 10.7.1. Liquid Biopsy in Cancer Diagnostics: Market Analysis in Japan by Sample Type (2018–2026) 10.7.2. Liquid Biopsy in Cancer Diagnostics: Market Analysis in Japan by Technique (2018–2026) 10.7.3. Liquid Biopsy in Cancer Diagnostics: Market Analysis in UK by Biomarker Type (2018–2026) 10.7.4. Liquid Biopsy in Cancer Diagnostics: Market Analysis in Japan by End User (2018–2026) 11. Market Dynamics 11.1. Market Drivers 11.2. Market Barriers 12. PEST Analysis 13. Conclusion and Future Perspective 14. Appendix 14.1. Bibliography 14.2. Report Methodology 15. DelveInsight Capabilities 16. Disclaimer 17. About DelveInsight

Table 1: Competitive Analysis Table 2: Liquid Biopsy in Cancer Diagnostics Market Analysis in the 7MM (2018–2026) Table 3: Liquid Biopsy in Cancer Diagnostics Market Analysis in the 7MM by Sample Type (2018–2026) Table 4: Liquid Biopsy in Cancer Diagnostics Market Analysis in the 7MM by Technique (2018–2026) Table 5: Liquid Biopsy in Cancer Diagnostics Market Analysis in the 7MM by Biomarker Type (2018–2026) Table 6: Liquid Biopsy in Cancer Diagnostics Market Analysis in the 7MM by End User (2018–2026) Table 7: Liquid Biopsy in Cancer Diagnostics United States Market Analysis (2018–2026) Table 8: Liquid Biopsy in Cancer Diagnostics Market Analysis in the US by Sample Type (2018-2026) Table 9: Liquid Biopsy in Cancer Diagnostics Market Analysis in the US by Technique (2018-2026) Table 10: Liquid Biopsy in Cancer Diagnostics Market Analysis in the US by Biomarker Type (2018–2026) Table 11: Liquid Biopsy in Cancer Diagnostics Market Analysis in the US by End User (2018-2026) Table 12: Liquid Biopsy in Cancer Diagnostics Germany Market Analysis (2018–2026) Table 13: Liquid Biopsy in Cancer Diagnostics Market Analysis in Germany by Sample Type (2018-2026) Table 14: Liquid Biopsy in Cancer Diagnostics Market Analysis in Germany by Technique (2018-2026) Table 15: Liquid Biopsy in Cancer Diagnostics Market Analysis in Germany by Biomarker Type (2018–2026) Table 16: Liquid Biopsy in Cancer Diagnostics Market Analysis in Germany by End User (2018-2026) Table 17: Liquid Biopsy in Cancer Diagnostics France Market Analysis (2018–2026) Table 18: Liquid Biopsy in Cancer Diagnostics Market Analysis in France by Sample Type (2018-2026) Table 19: Liquid Biopsy in Cancer Diagnostics Market Analysis in France by Technique (2018-2026) Table 20: Liquid Biopsy in Cancer Diagnostics Market Analysis in France by Biomarker Type (2018–2026) Table 21: Liquid Biopsy in Cancer Diagnostics Market Analysis in France by End User (2018-2026) Table 22: Liquid Biopsy in Cancer Diagnostics Spain Market Analysis (2018–2026) Table 23: Liquid Biopsy in Cancer Diagnostics Market Analysis in Spain by Sample Type (2018-2026) Table 24: Liquid Biopsy in Cancer Diagnostics Market Analysis in Spain by Technique (2018-2026) Table 25: Liquid Biopsy in Cancer Diagnostics Market Analysis in Spain by Biomarker Type (2018–2026) Table 26: Liquid Biopsy in Cancer Diagnostics Market Analysis in Spain by End User (2018-2026) Table 27: Liquid Biopsy in Cancer Diagnostics Italy Market Analysis (2018–2026) Table 28: Liquid Biopsy in Cancer Diagnostics Market Analysis in Italy by Sample Type (2018-2026) Table 29: Liquid Biopsy in Cancer Diagnostics Market Analysis in Italy by Technique (2018-2026) Table 30: Liquid Biopsy in Cancer Diagnostics Market Analysis in Italy by Biomarker Type (2018–2026) Table 31: Liquid Biopsy in Cancer Diagnostics Market Analysis in Italy by End User (2018-2026) Table 32: Liquid Biopsy in Cancer Diagnostics United Kingdom Market Analysis (2018–2026) Table 33: Liquid Biopsy in Cancer Diagnostics Market Analysis in the UK by Sample Type (2018-2026) Table 34: Liquid Biopsy in Cancer Diagnostics Market Analysis in the UK by Technique (2018-2026) Table35: Liquid Biopsy in Cancer Diagnostics Market Analysis in the UK by Biomarker Type (2018–2026) Table 36: Liquid Biopsy in Cancer Diagnostics Market Analysis in the UK by End User (2018-2026) Table 37: Liquid Biopsy in Cancer Diagnostics Japan Market Analysis (2018–2026) Table 38: Liquid Biopsy in Cancer Diagnostics Market Analysis in Japan by Sample Type (2018-2026) Table 39: Liquid Biopsy in Cancer Diagnostics Market Analysis in Japan by Technique (2018-2026) Table 40: Liquid Biopsy in Cancer Diagnostics Market Analysis in Japan by Biomarker Type (2018–2026) Table 41: Liquid Biopsy in Cancer Diagnostics Market Analysis in Japan by End User (2018-2026)

Guardant Health, Qiagen, F. Hoffmann-La Roche AG, Inviata, ArcherDx, Bio-Techne., Resolution Bioscience & LabCorp., Personal Genome Diagnostics., Helio Health, Lucence, Foundation medicine Inc.., Biocept, Sysmex Corporation, Veridex LLC and Biodesix, among others.